HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark R Lackner Selected Research
Mark R Lackner Research Topics
Disease
39
Neoplasms (Cancer)
01/2020 - 07/2008
22
Breast Neoplasms (Breast Cancer)
01/2020 - 07/2008
4
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 04/2012
3
Disease Progression
01/2020 - 11/2016
3
Lung Neoplasms (Lung Cancer)
01/2019 - 12/2011
3
Melanoma (Melanoma, Malignant)
01/2018 - 12/2011
3
Circulating Neoplastic Cells
04/2012 - 09/2010
2
Ovarian Epithelial Carcinoma
07/2015 - 01/2015
2
Colorectal Neoplasms (Colorectal Cancer)
04/2014 - 08/2009
1
Prostatic Neoplasms (Prostate Cancer)
01/2020
1
Neoplasm Metastasis (Metastasis)
01/2019
1
Adrenal Gland Neoplasms (Adrenal Cancer)
01/2018
1
Endometrial Neoplasms (Endometrial Cancer)
11/2016
1
Renal Cell Carcinoma (Grawitz Tumor)
10/2016
1
Hyperglycemia
10/2016
1
Exanthema (Rash)
10/2016
1
Hypoxia (Hypoxemia)
10/2016
1
Urinary Bladder Neoplasms (Bladder Cancer)
01/2016
1
Ovarian Neoplasms (Ovarian Cancer)
07/2015
1
Multiple Myeloma
03/2013
1
Hematologic Neoplasms (Hematological Malignancy)
03/2013
1
Colonic Neoplasms (Colon Cancer)
06/2012
1
Pancreatic Neoplasms (Pancreatic Cancer)
12/2011
1
Genomic Instability
04/2009
1
Neuroblastoma
09/2008
Drug/Important Bio-Agent (IBA)
18
Biomarkers (Surrogate Marker)
IBA
01/2020 - 07/2008
8
Estrogen Receptors
IBA
01/2020 - 08/2009
8
Proteins (Proteins, Gene)
FDA Link
10/2016 - 12/2008
7
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2020 - 07/2009
6
2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidine
IBA
12/2017 - 07/2010
6
Phenobarbital (Luminal)
FDA Link
10/2016 - 07/2008
5
Formaldehyde (Formol)
FDA Link
01/2019 - 01/2014
5
Paraffin
IBA
01/2019 - 01/2014
4
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 07/2009
4
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2018 - 07/2009
4
Phosphotransferases (Kinase)
IBA
01/2012 - 12/2008
3
TOR Serine-Threonine Kinases
IBA
11/2016 - 12/2011
3
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
11/2016 - 04/2009
3
Tensins
IBA
11/2016 - 04/2009
2
3- (4- (2- (2- chloro- 4- fluorophenyl)- 1- (1H- indazol- 5- yl)but- 1- en- 1- yl)phenyl)acrylic acid
IBA
01/2019 - 01/2016
2
ErbB Receptors (EGF Receptor)
IBA
12/2017 - 06/2011
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
12/2017 - 04/2012
2
Circulating Tumor DNA
IBA
11/2017 - 04/2012
2
Progesterone Receptors (Progesterone Receptor)
IBA
10/2016 - 11/2014
2
RNA (Ribonucleic Acid)
IBA
01/2016 - 11/2014
2
Docetaxel (Taxotere)
FDA Link
10/2015 - 09/2008
2
Platinum
IBA
07/2015 - 01/2015
2
Messenger RNA (mRNA)
IBA
11/2014 - 01/2014
2
Class I Phosphatidylinositol 3-Kinases
IBA
01/2014 - 07/2010
2
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
05/2012 - 07/2009
2
Mitogens
IBA
05/2012 - 06/2011
2
Protein Kinases (Protein Kinase)
IBA
01/2012 - 06/2011
2
Insulin-Like Peptides
IBA
05/2010 - 09/2008
2
IGF Type 1 Receptor (IGF 1 Receptor)
IBA
08/2009 - 09/2008
2
Monoclonal Antibodies
IBA
08/2009 - 09/2008
1
2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamide
IBA
01/2020
1
Hormones (Hormone)
IBA
01/2020
1
Androgens
IBA
01/2020
1
Cell-Free Nucleic Acids
IBA
01/2019
1
Vemurafenib
IBA
01/2018
1
cobimetinib
IBA
01/2018
1
Tyrosine Kinase Inhibitors
IBA
12/2017
1
Everolimus
FDA Link
10/2016
1
human ERBB2 protein
IBA
10/2016
1
Mechanistic Target of Rapamycin Complex 1
IBA
10/2016
1
Anastrozole (Arimidex)
FDA Link
Generic
10/2016
1
Fulvestrant (Faslodex)
FDA Link
01/2016
1
Aromatase Inhibitors
IBA
01/2016
1
Tamoxifen
FDA Link
Generic
01/2016
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2015
1
Capecitabine (Xeloda)
FDA Link
10/2015
1
Doxorubicin (Adriamycin)
FDA Link
Generic
10/2015
1
Periostin
IBA
07/2015
1
Trastuzumab (Herceptin)
FDA Link
05/2015
1
Ribosomal Proteins (Ribosomal Protein)
IBA
01/2015
1
Epidermal Growth Factor (EGF)
IBA
11/2014
1
Solutions
IBA
04/2014
1
Matrix Metalloproteinases (MMPs)
IBA
04/2014
1
ipatasertib
IBA
12/2013
1
onartuzumab
IBA
06/2013
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
06/2013
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
12/2012
1
Catenins
IBA
06/2012
1
pertuzumab
IBA
04/2012
1
1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- one
IBA
12/2011
1
MTOR Inhibitors
IBA
12/2011
1
Transcription Factors (Transcription Factor)
IBA
06/2011
1
MicroRNAs (MicroRNA)
IBA
06/2011
1
Epithelial Cell Adhesion Molecule
IBA
09/2010
1
Tumor Biomarkers (Tumor Markers)
IBA
09/2010
1
Estrogen Receptor Modulators (Antiestrogen)
IBA
08/2009
1
Insulin-Like Growth Factor II (Somatomedin A)
IBA
09/2008
1
Insulin-Like Growth Factor I (IGF-1)
IBA
09/2008
1
Glucose (Dextrose)
FDA Link
Generic
09/2008
Therapy/Procedure
10
Therapeutics
10/2016 - 07/2009
2
Adjuvant Chemotherapy
01/2019 - 01/2016
2
Drug Therapy (Chemotherapy)
11/2016 - 07/2015
2
Precision Medicine
01/2016 - 04/2014
1
Castration
01/2020
1
Immunotherapy
01/2019